First Header Logo Second Header Logo

Connection

Brian Hiestand to Natriuretic Peptide, Brain

This is a "connection" page, showing publications Brian Hiestand has written about Natriuretic Peptide, Brain.
Connection Strength

0.431
  1. Hiestand B, Abraham WT. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials. Curr Cardiol Rep. 2007 May; 9(3):182-6.
    View in: PubMed
    Score: 0.285
  2. Maisel AS, Peacock WF, Shah KS, Clopton P, Diercks D, Hiestand B, Kontos MC, Mueller C, Nowak R, Chen WJ, Collins SP. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. Am J Emerg Med. 2011 Oct; 29(8):924-31.
    View in: PubMed
    Score: 0.089
  3. Martindale JL, Wakai A, Collins SP, Levy PD, Diercks D, Hiestand BC, Fermann GJ, deSouza I, Sinert R. Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis. Acad Emerg Med. 2016 Mar; 23(3):223-42.
    View in: PubMed
    Score: 0.033
  4. Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veldhuisen DJ. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011 Aug; 13(8):846-51.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.